Cleerly LABS vs KardiaAI
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a detailed, non-invasive anatomical assessment of coronary arteries to quantify plaque burden, characterize plaque types, and detect stenosis using CCTA. This tool is ideal for clinicians seeking to personalize heart disease management and track disease progression over time based on comprehensive coronary artery imaging.
View Cleerly LABS →Choose KardiaAI if…
Choose KardiaAI if you need an AI-powered solution for analyzing ambulatory ECG rhythms to detect various cardiac conditions such as atrial fibrillation, bradycardia, or tachycardia. This tool is best suited for integrating into mobile apps or web platforms to provide medical-grade accuracy for heart rhythm data and support continuous or intermittent arrhythmia monitoring.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | KardiaAI |
|---|---|---|
| Pricing | Varies | Subscription-based for advanced features and services. |
| Deployment | Cloud, On-premise | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIKardiaAI excels in usability due to its widespread accessibility and ease of use for both patients and healthcare professionals, often through mobile apps and portable devices. Its simple, instant ECG analysis on a smartphone makes it highly convenient for broad monitoring and early detection, with nurses reporting better ease of use and patient satisfaction.
Clinical Value
Cleerly LABSCleerly LABS offers a more profound and comprehensive diagnostic capability by characterizing coronary plaque beyond just stenosis and detecting ischemia from CCTA. This detailed anatomical and pathological assessment aims to fundamentally shift heart disease management and prevention, with evidence showing a reduction in heart attacks and improved diagnostic accuracy over traditional methods.
Pricing & Value
KardiaAIKardiaAI offers a significantly lower, subscription-based pricing model, making it highly accessible for widespread patient monitoring and early arrhythmia detection. While Cleerly LABS addresses a high-value diagnostic need, its per-analysis cost, often out-of-pocket, presents a much higher financial barrier compared to KardiaAI's affordable subscriptions.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA availability, and robust integration capabilities. Cleerly LABS offers direct integration with PACS, RIS, and EHR via its proxy for imaging workflows, while KardiaAI provides comprehensive SDK/API options for integrating its AI library and patient data into various enterprise systems and EHRs like Epic.
Innovation
Cleerly LABSWhile KardiaAI has consistently innovated in accessible ECG technology, Cleerly LABS represents a more disruptive innovation by fundamentally changing how coronary artery disease is assessed. Its AI-powered, quantitative characterization of plaque volume and composition from CCTA, beyond traditional stenosis measurement, aims to establish a new standard of care for preventing heart attacks.
Support & Docs
KardiaAIKardiaAI (AliveCor) provides more extensive and transparent support resources, including detailed FAQs, user manuals, getting started guides, and direct contact information for customer support. They also offer a resource hub with publications and developer documentation. Cleerly LABS mentions IT integration support, but public-facing documentation and general customer support resources are not as readily apparent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | KardiaAI |
|---|---|---|
| Name | Cleerly LABS | KardiaAI |
| Company | Cleerly | AliveCor |
| Primary Modality/Input | Coronary CT angiography (CCTA) | Ambulatory ECG rhythms |
| Primary Analytical Focus | AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time | AI-powered ECG analysis library, detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering and noisy ECG detection |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or KardiaAI
Backers
Who funded each tool's parent company.